Meridian Bioscience
VIVO
#4853
Rank
$1.48 B
Marketcap
$33.97
Share price
0.00%
Change (1 day)
24.02%
Change (1 year)

Revenue for Meridian Bioscience (VIVO)

Revenue in 2022 (TTM): $0.33 Billion USD

According to Meridian Bioscience's latest financial reports the company's current revenue (TTM ) is $0.33 Billion USD. In 2021 the company made a revenue of $0.31 Billion USD an increase over the revenue in the year 2020 that were of $0.29 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Meridian Bioscience from 1996 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) $0.33 B6.29%
2021 $0.31 B4.73%
2020 $0.29 B51.89%
2019 $0.19 B-7.43%
2018 $0.21 B3.16%
2017 $0.20 B5.37%
2016 $0.19 B0.9%
2015 $0.19 B1%
2014 $0.19 B2.08%
2013 $0.18 B5.32%
2012 $0.17 B9.77%
2011 $0.16 B18.08%
2010 $0.13 B-11.91%
2009 $0.15 B11.67%
2008 $0.14 B9.36%
2007 $0.12 B14.14%
2006 $0.11 B13.32%
2005 $99.03 M23.35%
2004 $80.28 M18.19%
2003 $67.92 M10.18%
2002 $61.65 M12.45%
2001 $54.82 M-5.5%
2000 $58.02 M1.79%
1999 $57 M56.59%
1998 $36.4 M1.11%
1997 $36 M13.92%
1996 $31.6 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$2.83 B 751.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$42.34 B 12,615.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.82 B 5,854.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.98 B 1,097.41%๐Ÿ‡บ๐Ÿ‡ธ USA